Entyvio 108 MG/0.68 ML pen 0.68ML
Ended Awarded
- Contract number
- SPE2DB25FSDKN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,671
Award facts
- Contract value 100% obligated
- $19,670.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,670.56 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Entyvio (vedolizumab) 108 mg/0.68 ml pen auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 12, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which enables the contractor to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of DLA contracts demonstrates its capability to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains. Entyvio is a specialty medication used in the treatment of inflammatory bowel conditions, reflecting the company's role in supplying specialized healthcare commodities to support Defense Health Agency and other federal healthcare customers worldwide.
Quick answers
Who was awarded contract SPE2DB25FSDKN?
SPE2DB25FSDKN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FSDKN worth?
The government has obligated $19,671 on SPE2DB25FSDKN.
Is contract SPE2DB25FSDKN an order under another contract?
Yes. SPE2DB25FSDKN is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSDKN competed?
The extent of competition for SPE2DB25FSDKN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award